FlyteHealth Review
Best for: Members of employers or health plans wanting physician-led obesity care
FlyteHealth is an obesity-medicine telehealth platform distributed mainly through employers, payers, and health plans, with care led by board-certified obesity-medicine physicians plus nurse practitioners, dietitians, and care coordinators. GLP-1s may be prescribed when appropriate, alongside non-GLP-1 anti-obesity drugs, labs, nutrition, and lifestyle support. It is not a direct cash-pay GLP-1 vendor, though individuals can access it via the MDsave/Tendo marketplace and a FlyteHealth Direct self-pay option. Reported outcomes include roughly 13 to 16 percent weight loss over twelve months.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
FlyteHealth is a solid telehealth option with balanced features and pricing.
Score Breakdown
✓ Pros
- •Care led by board-certified obesity-medicine physicians
- •Multidisciplinary team with NPs, dietitians, and care coordinators
- •Published outcomes of about 13 to 16 percent weight loss over 12 months
- •High GLP-1 medication adherence (around 86 percent in reported data)
- •Comprehensive cardiometabolic care beyond GLP-1 alone
- •MDsave and FlyteHealth Direct give some self-pay access
✗ Cons
- •Distributed primarily via employers, payers, and health plans, not direct cash-pay
- •Access is largely gated behind employer or plan sponsorship
- •GLP-1 is prescribed only when appropriate, not guaranteed
- •Self-pay pricing is not publicly listed (contact required)
- •Less suited to consumers wanting fast direct-to-door GLP-1
Ready to start with FlyteHealth?
See current pricing and start your free consultation.
Sources & methodology
Our FlyteHealth review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to FlyteHealth
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with FlyteHealth?
See current pricing and start your free consultation.